undamentalytics Newsletter
Sign in

Sight Sciences, Inc. balance sheet

At the end of fiscal 2025, Sight Sciences, Inc. had total assets of $115m, total liabilities of $51.4m and shareholders' equity of $63.9m. It held $92.0m in cash against $42.4m of debt: net cash of $49.6m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents622611851381209280
Receivables591514111011
Inventory3368686
Total current assets71277210163140113101
Total assets73280213167143115105
Accounts payable2332212
Total current liabilities9141812151120
Short-term debt00020010
Long-term debt32333332394031
Total debt35353535404251
Total liabilities44485346555152
Shareholders' equity−89232160120886453
Non-controlling interests and other (assets − liabilities − equity)117——————
Net debt (negative = net cash)−27−226−150−103−80−50−29
Shares outstanding29m—48m49m51m53m55m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: SGHT vs TELAPDEX vs SGHTLUNG vs SGHTIRMD vs SGHT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Sight Sciences, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sight Sciences, Inc.